Comparing the effects of commercial to open initial specimen diversion techniques on clinical outcomes and institutional costs
The clinical outcomes associated with using commercial versus open ISDTs (initial specimen diverting techniques) remain unclear. This multicenter study showed that switching from the commercial to open ISDT did not change blood culture contamination rates, length of stay, or days of therapy with antibiotics, but did reduce laboratory-associated costs.
Authors
- Sabra Shay (ORCID: https://orcid.org/0009-0007-0976-9966)
- Todd Michael Lasco (ORCID: https://orcid.org/0000-0002-5405-7067)
- Mayar Al Mohajer (ORCID: https://orcid.org/0000-0002-0333-1070)
- Margaret Reed
- Corina Lopez
- Victoria McArdle
- Bradley Lembcke
- Erin H. Yang
Institutions
- Baylor College of Medicine (US)
- Hadassah Medical Center (IL)
- Massachusetts General Hospital (US)
- Theradex Oncology (United States) (US)
Publication Details
- Journal
- Infection Control and Hospital Epidemiology
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1017/ice.2026.10412
- Primary Topic
- Bacterial Identification and Susceptibility Testing
- Type
- article
- Field-Weighted Citation Impact
- 0.00